Colony Group LLC cut its holdings in shares of Colgate-Palmolive Company (NYSE:CL) by 5.0% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 16,200 shares of the company’s stock after selling 850 shares during the quarter. Colony Group LLC’s holdings in Colgate-Palmolive were worth $1,186,000 at the end of the most recent reporting period.

Several other institutional investors have also made changes to their positions in the company. OLD Mutual Customised Solutions Proprietary Ltd. increased its position in shares of Colgate-Palmolive by 12.9% during the 1st quarter. OLD Mutual Customised Solutions Proprietary Ltd. now owns 28,790 shares of the company’s stock valued at $2,107,000 after purchasing an additional 3,290 shares during the last quarter. Notis McConarty Edward increased its position in shares of Colgate-Palmolive by 4.9% during the 1st quarter. Notis McConarty Edward now owns 14,550 shares of the company’s stock valued at $1,065,000 after purchasing an additional 675 shares during the last quarter. Harbour Capital Advisors LLC purchased a new stake in shares of Colgate-Palmolive during the 1st quarter valued at $121,000. Marshall & Sullivan Inc. WA increased its position in shares of Colgate-Palmolive by 4.7% during the 1st quarter. Marshall & Sullivan Inc. WA now owns 43,279 shares of the company’s stock valued at $3,103,000 after purchasing an additional 1,926 shares during the last quarter. Finally, Caxton Associates LP purchased a new stake in shares of Colgate-Palmolive during the 1st quarter valued at $8,417,000. 73.16% of the stock is owned by hedge funds and other institutional investors.

TRADEMARK VIOLATION WARNING: “Colgate-Palmolive Company (CL) Shares Sold by Colony Group LLC” was originally reported by Watch List News and is the property of of Watch List News. If you are reading this news story on another site, it was illegally stolen and republished in violation of United States and international trademark and copyright legislation. The original version of this news story can be read at https://www.watchlistnews.com/colgate-palmolive-company-cl-shares-sold-by-colony-group-llc/1557182.html.

In other news, insider Patricia Verduin sold 3,833 shares of the company’s stock in a transaction dated Thursday, June 15th. The stock was sold at an average price of $75.67, for a total value of $290,043.11. Following the completion of the transaction, the insider now owns 53,022 shares of the company’s stock, valued at $4,012,174.74. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CFO Dennis J. Hickey sold 73,872 shares of the company’s stock in a transaction dated Thursday, August 3rd. The stock was sold at an average price of $71.80, for a total value of $5,304,009.60. Following the completion of the transaction, the chief financial officer now directly owns 484,985 shares of the company’s stock, valued at approximately $34,821,923. The disclosure for this sale can be found here. In the last 90 days, insiders sold 221,802 shares of company stock valued at $15,983,976. Company insiders own 1.02% of the company’s stock.

Colgate-Palmolive Company (NYSE CL) traded down 0.03% on Tuesday, hitting $72.00. The stock had a trading volume of 641,005 shares. The company has a market capitalization of $63.42 billion, a price-to-earnings ratio of 26.76 and a beta of 0.80. The firm has a 50-day moving average of $71.61 and a 200 day moving average of $73.32. Colgate-Palmolive Company has a 52 week low of $63.43 and a 52 week high of $77.27.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Friday, July 21st. The company reported $0.72 EPS for the quarter, hitting analysts’ consensus estimates of $0.72. The business had revenue of $3.83 billion during the quarter, compared to analysts’ expectations of $3.89 billion. Colgate-Palmolive had a return on equity of 3,121.95% and a net margin of 15.83%. The business’s quarterly revenue was down .5% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.70 earnings per share. On average, analysts predict that Colgate-Palmolive Company will post $2.89 earnings per share for the current year.

Several equities research analysts have recently issued reports on CL shares. Bank of America Corporation raised their target price on Colgate-Palmolive from $78.00 to $80.00 and gave the company a “buy” rating in a research report on Wednesday, May 31st. Zacks Investment Research raised Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $83.00 target price for the company in a research report on Tuesday, July 4th. Royal Bank Of Canada reaffirmed a “hold” rating and set a $74.00 target price on shares of Colgate-Palmolive in a research report on Friday, June 30th. Jefferies Group LLC raised their target price on Colgate-Palmolive from $76.00 to $77.00 and gave the company a “hold” rating in a research report on Thursday, July 6th. Finally, Vetr lowered Colgate-Palmolive from a “buy” rating to a “hold” rating and set a $76.67 target price for the company. in a research report on Wednesday, May 17th. Two analysts have rated the stock with a sell rating, twelve have assigned a hold rating and two have assigned a buy rating to the company. The stock currently has an average rating of “Hold” and a consensus price target of $75.82.

Colgate-Palmolive Profile

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with Analyst Ratings Network's FREE daily email newsletter.